Revision 7228222 of "Jonathan Blackburn" on simplewiki

{{RfD|I do not believe this person to be notable. All the claims in the article appear to be inline with what you'd expect from somebody working in this field, nothing notable.}}
{{wikify|reason=no internal links; external inline in the text|date=April 2019}}
{{complex|date=April 2019}}
Professor '''Jonathan Michael Blackburn''' (PhD MASSAf) is a British chemist and proteomics researcher. He is currently Chief Scientific Officer of Sengenics<ref>{{Cite web|url=https://www.sengenics.com/boardofdirectors/|title=Sengenics Functional Proteomics {{!}} Board of Directors|language=en-GB|access-date=2019-03-18}}</ref>, a functional proteomics company and is best known for inventing the KREX<ref>{{Cite web|url=https://www.sengenics.com/krex/|title=The Fundamental Principle of Krex™ Technology {{!}} Sengenics|language=en-GB|access-date=2019-03-18}}</ref> protein array technology platform, a proprietary protein folding technology that produces full-length, correctly folded and functionally verified human proteins for various autoantibody biomarker discovery applications.

=== Research ===
Blackburn has published more than 153 research articles that have been cited over 1,803 times<ref>{{Cite web|url=https://www.researchgate.net/profile/Jonathan_Blackburn2|title=Jonathan M Blackburn {{!}} University of Cape Town, Cape Town {{!}} UCT {{!}} Institute of Infectious Disease & Molecular Medicine (IIDMM)|website=ResearchGate|language=en|access-date=2019-03-18}}</ref> specifically in research areas focusing on mechanistic enzymology, protein biochemistry, molecular biology, proteomics, custom protein microarrays, metabolomics, genomics in diagnostic marker discovery and validation, and polymorphic variation on protein function<ref>{{Cite web|url=http://www.idm.uct.ac.za/idm/members/full-members/jonathan-blackburn|title=Professor Jonathan Blackburn PhD MASSAf {{!}} Infectious Disease & Molecular Medicine|website=www.idm.uct.ac.za|language=en|access-date=2019-03-22}}</ref>. He is also listed as the inventor and patent holder for the following applications: Arrays<ref>{{Cite web|url=https://patents.justia.com/patent/20180305840|title=US Patent Application for ARRAYS Patent Application (Application #20180305840 issued October 25, 2018) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref><ref>{{Cite web|url=https://patents.justia.com/patent/20110172123|title=US Patent Application for Arrays Patent Application (Application #20110172123 issued July 14, 2011) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref><ref>{{Cite web|url=https://patents.justia.com/patent/20040002078|title=US Patent Application for Arrays Patent Application (Application #20040002078 issued January 1, 2004) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref><ref>{{Cite web|url=https://patents.justia.com/patent/20030228709|title=US Patent Application for Arrays Patent Application (Application #20030228709 issued December 11, 2003) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref>, Method of detecting and/or quantifying an analyte in a biological sample<ref>{{Cite web|url=https://patents.justia.com/patent/9518986|title=US Patent for Method of detecting and/or quantifying an analyte in a biological sample Patent (Patent # 9,518,986 issued December 13, 2016) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref><ref>{{Cite web|url=https://patents.justia.com/patent/20140302492|title=US Patent Application for METHOD OF DETECTING AND/OR QUALIFYING AN ANALYTE IN A BIOLOGICAL SAMPLE Patent Application (Application #20140302492 issued October 9, 2014) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref>, Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state<ref>{{Cite web|url=https://patents.justia.com/patent/8999897|title=US Patent for Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state Patent (Patent # 8,999,897 issued April 7, 2015) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref>, Protein arrays and uses thereof<ref>{{Cite web|url=https://patents.justia.com/patent/20090239761|title=US Patent Application for Protein arrays and uses thereof Patent Application (Application #20090239761 issued September 24, 2009) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref>, Method for producing proteins tagged at the N- or C-terminus<ref>{{Cite web|url=https://patents.justia.com/patent/7094568|title=US Patent for Method for producing proteins tagged at the N- or C-terminus Patent (Patent # 7,094,568 issued August 22, 2006) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref>, Target and method<ref>{{Cite web|url=https://patents.justia.com/patent/20030180957|title=US Patent Application for Target and method Patent Application (Application #20030180957 issued September 25, 2003) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref> and Method<ref>{{Cite web|url=https://patents.justia.com/patent/20030073811|title=US Patent Application for Method Patent Application (Application #20030073811 issued April 17, 2003) - Justia Patents Search|website=patents.justia.com|access-date=2019-03-22}}</ref>.
<br />

=== Career ===
Blackburn completed his undergraduate and postgraduate degrees at [[University of Oxford]] where he studied penicillin biosynthesis under the supervision of [[:en:Jack_Edward_Baldwin|Sir Jack Baldwin, FRS]]. He then carried out postdoctoral research on the directed evolution of new enzymes at the [https://www2.mrc-lmb.cam.ac.uk/ MRC Laboratory of Molecular Biology, University of Cambridge] with [[:en:Alan_Fersht|Sir Alan Fersht, FRS]].

In 1999, Blackburn founded a start-up biotechnology company in the UK, [https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapid=897638 Sense Proteomic Ltd], to commercialise the protein function microarray technology invented in his academic group. Following a takeover by Procognia Ltd in 2002, Blackburn became the chief scientist of the merged organisation<ref>{{Cite web|url=https://innovation.ox.ac.uk/news/procognia-ltd-acquires-sense-proteomic-closes-4-million-financing/|title=Procognia Ltd Acquires Sense Proteomic|website=Oxford University Innovation|access-date=2019-03-22}}</ref>, which employed 70 scientists worldwide, a post he held until early 2006.

In 2006, he co-founded the Centre for Proteomic & Genomic Research – a not-for-profit organisation funded by a R20m grant from the [http://www.cvp.co.za/clients/past-clients/item/cape-biotech Cape Biotech Trust] to provide equipment infrastructure and expertise in the functional genomics sector – where he held the post of executive director of research until he was appointed to the South African Research Chair in Applied Proteomics & Chemical Biology<ref>{{Cite web|url=http://www.uct.ac.za/main/research/groups/south-african-research-chairs|title=South African research chairs {{!}} University of Cape Town|website=www.uct.ac.za|language=en|access-date=2019-03-22}}</ref><ref>{{Cite web|url=http://www.chemsysbio.uct.ac.za/csb/research/blackburn|title=Blackburn Group {{!}} Division of Chemical and Systems Biology|website=www.chemsysbio.uct.ac.za|language=en|access-date=2019-03-22}}</ref> at the [http://www.uct.ac.za/ University of Cape Town] in 2008.

Blackburn is currently the Chief Scientific Officer of Sengenics, heading the advancement and development of novel use of the KREX protein array technology platform. He is also a full-time academic member and head of University of Cape Town’s Applied Proteomics & Chemical Biology group which has a goal of creating a pipeline for each lead program from discovery through to quantitation and application in the human health sector.

=== Awards and recognition ===
Blackburn has served on a number of local, national and international committees including: National Health Research Committee ([http://www.health.gov.za/ Department of Health, RSA]<ref>{{Cite journal|last=Mayosi|first=B. M.|last2=Friedman|first2=I. B.|last3=Blackburn|first3=J. M.|last4=Paruk|first4=F.|date=2014-7|title=National expenditure on health research in South Africa: what is the benchmark?|url=http://www.scielo.org.za/scielo.php?script=sci_abstract&pid=S0256-95742014000700013&lng=en&nrm=iso&tlng=en|journal=SAMJ: South African Medical Journal|volume=104|issue=7|pages=466–467|issn=0256-9574}}</ref>); the biotechnology subcommittee of the [https://iupac.org/ International Union of Pure & Applied Chemistry]<ref>{{Cite web|url=https://old.iupac.org/divisions/III/members.html|title=International Union of Pure and Applied Chemistry|website=old.iupac.org|access-date=2019-03-22}}</ref>; the Nominations and Elections Committee, [https://www.hupo.org/ Human Proteome Organisation (HUPO)]; the Faculty of Health Sciences Research Committee; and the [http://www.idm.uct.ac.za/ IIDMM] Executive Committee. He also sits on the editorial advisory boards of the [https://pubs.acs.org/journal/jprobs Journal of Proteome Research], the [http://www.hoajonline.com/Journal-of-Proteome-Science-and-Computational.html Journal of Proteome Science & Computational Biology], and [https://www.tandfonline.com/loi/ieru20 Expert Review of Proteomics].

==References==
{{reflist}}

{{DEFAULTSORT:Blackburn, Jonathan}}
[[Category:Living people]]
[[Category:Year of birth missing (living people)]]
[[Category:British scientists]]
All content in the above text box is licensed under the Creative Commons Attribution-ShareAlike license Version 4 and was originally sourced from https://simple.wikipedia.org/w/index.php?oldid=7228222.
This site is not affiliated with or endorsed in any way by the Wikimedia Foundation or any of its affiliates. In fact, we fucking despise them.